Sep
5
Wed
Recovery Within Reach: Building Team Expertise in Office-Based Opioid Treatment (OBOT) @ Foundation Auditorium
Sep 5 @ 8:30 am – 12:45 pm

Opioid addiction is a chronic, relapsing brain disease that affects millions of Americans and produces a tremendous burden on the healthcare system. In 2002, U.S. physicians gained the opportunity to treat opioid-addicted patients with buprenorphine in primary care settings, commonly referred to as office-based opioid treatment (OBOT). OBOT has been shown to be effective in primary care settings and impacts public health through the reduction of opioid use, opioid overdose mortality, and transmission of infectious diseases. However, it remains underutilized.

One consistently cited barrier preventing OBOT expansion is lack of adequate clinical support given the additional needs for patient monitoring. Successful medication-assisted treatment (MAT) requires a team-based approach just like treatment for other chronic diseases. In addition, treatment is more effective when providers can use a trauma-informed and gender-responsive treatment plan.

The goal of this companion program to the AAAP Clinical Support System: Buprenorphine Office-Based Treatment for Opioid Use Disorders (the “Half and Half” Course) is to increase the comfort level and expertise of the healthcare team by outlining a team approach, trauma-informed interventions, gender-responsive care, and making recommendations for the implementation of buprenorphine OBOT.

Location
Please note: This conference is being held at the NC Medical Society Foundation Auditorium on 222 N. Person Street in Raleigh, NC 27601.
 For a map to the NC Medical Society, please click here. 

If you are a prescriber in primary care, emergency medicine, pain management, psychiatric, HIV and addiction medicine, you may interested in “Physicians’ Clinical Support System: Buprenorphine Office-Based Treatment for Opioid Use Disorders, The “Half and Half” Course on the same date.

By registering for this conference, you are granting permission for your contact information to be shared with the North Carolina Medical Society Foundation, which is a collaborating partner of this continuing education activity.

Objectives

  • Describe the presented framework of office-based opioid treatment (OBOT) including practice changes, medications used, psychosocial services, and integration/coordination components
  • Utilize evidence-based interventions that are trauma-informed and gender-responsive to treat persons with substance use disorders
  • Define the roles of an effective practice team, including primary care and behavioral health clinicians, working together with patients and families, and using a systematic and cost-effective approach to provide patient-centered care for opioid and other substance use disorders
  • Increase medical and behavioral health professionals’ receptivity and capability to work collaboratively as they evaluate and manage opioid and other substance use disorders using SBIRT (screening, brief intervention and referral to treatment)
  • List key components of evidence-based and effective OBOT

Click here to be taken to registration

Click here for a program brochure

Providers’ Clinical Support System: Buprenorphine Office-Based Treatment for Opioid Use Disorders, The “Half and Half” Course @ Foundation Auditorium
Sep 5 @ 9:00 pm – 10:00 pm

Description

Opioid dependence is epidemic in the United States. While progress has been made in training providers, the gap in providing effective treatment of opioid use disorders continues to widen, moving beyond heroin addicted individuals to a much larger and diverse segment of the population. This increase is predominantly due to an alarming increase in addiction to prescription opioid analgesic medications.

Buprenorphine, the most recent addition to the pharmacotherapies available to treat opioid dependence, is novel among the opioid pharmacotherapies because of its partial agonist properties. It has been placed on Schedule III and is available by prescription from a physician’s office-based practice.

Recognizing the impact of this addiction, as well as learning how to treat opioid use disorders, are important steps in combating this ever growing medical problem. To obtain the waiver to prescribe, providers are required to take specialized training. PCSS-MAT uses the Half-and-Half format (first, 4.25 hours of face-to-face training with an instructor, followed by 3.75 hours of on-your-own-training that must be completed along with a post test). This training meets the requirements for physicians; however additional training is required for advanced practice providers.

The training focuses on specifics of treating patients with opioid use disorders in office-based settings and clinical vignettes to help trainees think through “real life” experiences in opioid use disorders treatment. Once the waiver training is completed in full, participants will receive a CME certificate of attendance from AAAP.

See brochure for complete information on credits.

By registering for this conference, you are granting permission for your contact information to be shared with the North Carolina Medical Society Foundation, which is a collaborating partner of this continuing education activity.

The program is recommended for prescribers in primary care, emergency medicine, pain management, psychiatric, HIV, and addiction medicine. (Not a prescriber? CLICK HERE)

Objectives

  • Define the federal Drug Abuse Treatment Act (DATA) of 2000 and the subsequent revisions that lists the criteria needed for Office-Based Opioid Treatment (OBOT)
  • List the criteria for establishing the diagnosis of opioid dependence
  • Distinguish between spontaneous withdrawal and precipitated withdrawal as well as the appropriate methods of buprenorphine induction
  • Describe and contrast the functions of full mu agonists, partial agonists, and antagonists
  • Explain the interplay between pain and addiction, and how buprenorphine can be used to help stabilize these patients
  • Describe the basic approach used in at least three different types of non-pharmacological treatment of opioid dependence
  • Describe three symptoms of opioid withdrawal or intoxication that mimic symptoms of a psychiatric disorder
  • Describe at least three factors to consider in determining if the patient is an appropriate candidate for office-based treatment with buprenorphine
  • Describe at least three areas that should be covered in the rules and expectations communicated to patients during the patient assessment process
  • List at least three situations in which patient information, with patient identity, can be shared under current laws protecting the patient’s confidentiality 42 CFR and HIPAA
  • Reduce and minimize buprenorphine misuse and diversion
  • Describe the drug interactions of buprenorphine and pediatric exposures

Click here for a brochure

Click here for registration